Geh Katharina J, Hubert Madlen, Winter Gerhard
a Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics , Ludwig-Maximilians Universität München , Munich , Germany.
J Microencapsul. 2016 Nov;33(7):595-604. doi: 10.1080/02652048.2016.1228706. Epub 2016 Sep 7.
Gelatine nanoparticles (GNPs) are biodegradable and biocompatible drug delivery systems with excellent clinical performances. A two-step desolvation is commonly used for their preparation, although this methodology has several shortcomings: lack of reproducibility, small scales and low yields. A straightforward and more consistent GNP preparation approach is presented here focusing on the development of a one-step desolvation with the use of a commercially available gelatine type. Controlled stirring conditions and ultrafiltration are used to achieve large-scale production of nanoparticles of up to 2.6 g per batch. Particle size distributions are conserved and comparable to those determined for two-step desolvation on small scale. Additionally, a range of cross-linking agents is examined for their effectiveness in stabilising GNPs as an alternative to glutaraldehyde. Glyceraldehyde demonstrated outstanding properties, which led to high colloidal stability. This approach optimises the manufacturing process and the scale-up of the production capacity, providing a clear potential for future applications.
明胶纳米颗粒(GNPs)是具有出色临床性能的可生物降解且生物相容的药物递送系统。虽然两步去溶剂化法通常用于其制备,但该方法存在一些缺点:缺乏可重复性、规模小且产率低。本文提出了一种直接且更一致的GNP制备方法,重点是开发使用市售明胶类型的一步去溶剂化法。使用受控搅拌条件和超滤来实现每批高达2.6克纳米颗粒的大规模生产。粒径分布得以保持,并且与小规模两步去溶剂化法所确定的粒径分布相当。此外,研究了一系列交联剂作为戊二醛的替代品在稳定GNPs方面的有效性。甘油醛表现出出色的性能,从而带来了高胶体稳定性。这种方法优化了制造工艺并扩大了生产能力规模,为未来应用提供了明显的潜力。